Many states are sacrificing the long-term health and sustainability of the legal cannabis market for theoretical short-term gains reaped by sky-high taxes.
While the United States Supreme Court reviews landmark challenges regarding the rights of cannabis consumers and Germany establishes a robust framework for legal adult-use, France has taken a dark, regressive turn.
“At the end of the day, lawmakers desire to roll back legalization has nothing to do with the law not working as intended, and everything to do with legislators disapproving of how their constituents voted on a major public policy issue.”
“Regulation works. Illicit marijuana providers don’t ask for or check for ID, but licensed businesses most certainly do.”
Lawmakers sent ten cannabis-related bills to the desk of Democratic Governor Abigail Spanberger for her review.
“For nearly five years, Alabama patients and their providers have lacked the ability to locally access medically necessary state-approved cannabis products from state-licensed dispensaries. Going forward, let’s hope lawmakers and regulators finally begin putting patients’ needs first.”
Researchers reported that those with a history of cannabis use “demonstrated significantly better cognitive performance.” Cannabis use “was not associated with increased risk of dementia” and researchers found “no supporting evidence of a causal link with [longitudinal] cognitive decline in later life.”
It’s not only consumers’ 2nd Amendment rights that are under assault. Historically, governments have sought to deny cannabis consumers many other rights as well, including their right to use the medicine that works best for them, or to exercise their freedom to choose to relax with a substance that’s objectively safer than alcohol. And every step of the way, NORML has been there to fight back on their behalf.